Germaine Helen Purcell, RN | |
1000 Brookhaven Dr, Aiken, SC 29803-2109 | |
(803) 641-2417 | |
Not Available |
Full Name | Germaine Helen Purcell |
---|---|
Gender | Female |
Speciality | Registered Nurse - Administrator |
Location | 1000 Brookhaven Dr, Aiken, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144560301 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
163WA2000X | Registered Nurse - Administrator | 48906 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Germaine Helen Purcell, RN 1000 Brookhaven Dr, Aiken, SC 29803-2109 Ph: (803) 641-2417 | Germaine Helen Purcell, RN 1000 Brookhaven Dr, Aiken, SC 29803-2109 Ph: (803) 641-2417 |
News Archive
A Duke University research team has found a way to help sporting officials detect whether an athlete's blood has been doped by an infusion of their own stored blood.
The memory of specific episodes is the base of autobiographical memory, but we do not know how the brain structures the experience to remember it in the long run.
Viral Genetics (Pink Sheets: VRAL), a biotechnology company that develops drug compounds for HIV/AIDS, autoimmune diseases, and cancer, is issuing this announcement in response to a series of press releases distributed by collegestock.com on August 25 and August 26, and an article published on Today's Financial News entitled "TFN Reader Grapevine: There's Something About Viral Genetics, Inc. (VRAL)," on August 25.
A study comparing breastfed and formula fed infants across time showed that the known beneficial effects of breastfeeding are greater than the potential risks associated with infant exposure to chemicals such as dioxins that may be present in breastmilk, according to a report published in the December issue (Volume 3, Number 4) of Breastfeeding Medicine.
Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today that it has initiated a Phase 2a clinical study of PRM-151 to evaluate the efficacy, safety, and tolerability of PRM-151 in preventing post-surgical scarring in glaucoma patients following glaucoma filtration surgery. There currently are no approved drugs for preventing post-surgical scarring in glaucoma, and there are no approved anti-fibrotic drug therapies in the U.S. or Europe for any fibrotic disease.
› Verified 5 days ago
Amber Melissa Gretzner, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 2050 Pine Log Rd, Aiken, SC 29803 Phone: 803-641-2740 Fax: 803-641-2526 | |
Debra Morgan Chalker, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 4180 Banks Mill Rd, Aiken, SC 29803 Phone: 803-221-6091 | |
Mrs. Melinda Sapp Sadler, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 Beaufort St Ne, Aiken, SC 29801 Phone: 803-643-4025 Fax: 803-643-4018 | |
Ms. Kelly Susanne Dacre, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1135 Gregg Hwy Nw, Aiken, SC 29801 Phone: 803-641-7700 | |
Kimya Katrese Justice, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1000 Clyburn Pl, Aiken, SC 29801 Phone: 803-380-7000 Fax: 803-502-8491 | |
Jamie Marie Simmons, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 Beaufort St Ne, Aiken, SC 29801 Phone: 803-502-4683 |